{
    "Trade/Device Name(s)": [
        "Applied Biosystems TaqPath COVID-19 Diagnostic PCR Kit",
        "TaqPath COVID-19 Diagnostic PCR Kit",
        "Applied Biosystems TaqPath COVID-19 Diagnostic PCR Assay Kit",
        "TaqPath COVID-19 Diagnostic PCR Control",
        "TaqPath COVID-19 Diagnostic PCR Control Dilution Buffer"
    ],
    "Submitter Information": "Life Technologies Corporation (a legal entity of Thermo Fisher Scientific)",
    "510(k) Number": "K233453",
    "Predicate Device Reference 510(k) Number(s)": [
        "K211079"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QQX"
    ],
    "Summary Letter Date": "October 20, 2023",
    "Summary Letter Received Date": "October 20, 2023",
    "Submission Date": "July 08, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3981"
    ],
    "Regulation Name(s)": [
        "Device To Detect And Identify Nucleic Acid Targets In Respiratory Specimens From Microbial Agents That Cause The SARS-CoV-2 Respiratory Infection And Other Microbial Agents When In A Multi-Target Test"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "SARS-CoV-2 RNA",
        "ORF1ab gene",
        "N gene",
        "S gene",
        "MS2 (internal process control)"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Anterior nasal swab"
    ],
    "Specimen Container(s)": [
        "Transport media",
        "BD universal viral transport medium (UVT)",
        "Viral transport media (VTM)"
    ],
    "Instrument(s)/Platform(s)": [
        "Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument",
        "Applied Biosystems QuantStudio 5 Dx Real-Time PCR Instrument",
        "KingFisher Flex Purification System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time reverse transcription polymerase chain reaction (RT-PCR)",
        "Multiplex PCR",
        "Automated nucleic acid extraction"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex PCR",
        "Automated test interpretation",
        "Nucleic acid extraction"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Control",
        "Dilution Buffer",
        "Multiplex Assay",
        "Software",
        "Extraction kit"
    ],
    "Document Summary": "FDA 510(k) summary for Applied Biosystems TaqPath COVID-19 Diagnostic PCR Kit using multiplex RT-PCR for qualitative detection of SARS-CoV-2 RNA in upper respiratory specimens",
    "Indications for Use Summary": "A real-time RT-PCR test for qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal and anterior nasal specimens from individuals with signs and symptoms of respiratory tract infection, intended as an aid in the diagnosis of COVID-19 when used with other clinical and laboratory findings",
    "fda_folder": "Microbiology"
}